Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.
暂无分享,去创建一个
Simon P Hoerstrup | Robert W Hitchcock | S. Hoerstrup | M. Emmert | R. Hitchcock | Maximilian Y Emmert
[1] Hua-Lin Wu,et al. Intramyocardial Peptide Nanofiber Injection Improves Postinfarction Ventricular Remodeling and Efficacy of Bone Marrow Cell Therapy in Pigs , 2010, Circulation.
[2] Zhonggang Feng,et al. An electro-tensile bioreactor for 3-D culturing of cardiomyocytes , 2005, IEEE Engineering in Medicine and Biology Magazine.
[3] Joshua M Hare,et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.
[4] Andreas Hess,et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.
[5] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[6] Ross A. Marklein,et al. The potential to improve cell infiltration in composite fiber-aligned electrospun scaffolds by the selective removal of sacrificial fibers. , 2008, Biomaterials.
[7] A. Hagège,et al. Long-Term Efficacy of Myoblast Transplantation on Regional Structure and Function After Myocardial Infarction , 2002, Circulation.
[8] Doris A Taylor,et al. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells , 2007, Nature Clinical Practice Cardiovascular Medicine.
[9] A. Haverich,et al. No Evidence of Transdifferentiation of Human Endothelial Progenitor Cells Into Cardiomyocytes After Coculture With Neonatal Rat Cardiomyocytes , 2006, Circulation.
[10] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[11] L. Amado,et al. The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. , 2008, Comparative medicine.
[12] Payam Akhyari,et al. Mechanical Stretch Regimen Enhances the Formation of Bioengineered Autologous Cardiac Muscle Grafts , 2002, Circulation.
[13] P. Menasché. Myoblast transplantation: feasibility, safety and efficacy , 2002, Annals of medicine.
[14] A. Zeiher,et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[15] J E Saffitz,et al. Pulsatile Stretch Remodels Cell-to-Cell Communication in Cultured Myocytes , 2000, Circulation research.
[16] Alessandro Giacomello,et al. Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice , 2010, Circulation research.
[17] Guy Salama,et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia , 2007, Nature.
[18] P. Doevendans,et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. , 2011, European heart journal.
[19] J. Hare,et al. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.
[20] P. V. van Wachem,et al. Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. , 2002, Biomaterials.
[21] Milica Radisic,et al. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. , 2011, Biomaterials.
[22] Milica Radisic,et al. Cardiac tissue engineering using perfusion bioreactor systems , 2008, Nature Protocols.
[23] R. Kloner,et al. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. , 2009, Regenerative medicine.
[24] P. Menasché. Stem cell therapy for heart failure: are arrhythmias a real safety concern? , 2009, Circulation.
[25] H. Chiang,et al. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. , 2006, Biomaterials.
[26] Gordon Keller,et al. Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development , 2008, Cell.
[27] J. Krieger,et al. Rat Adipose Tissue-Derived Stem Cells Transplantation Attenuates Cardiac Dysfunction Post Infarction and Biopolymers Enhance Cell Retention , 2010, PloS one.
[28] Thomas Eschenhagen,et al. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Giulio Cossu,et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.
[30] Gordana Vunjak-Novakovic,et al. Perfusion improves tissue architecture of engineered cardiac muscle. , 2002, Tissue engineering.
[31] Darrell H. Reneker,et al. Electrospinning process and applications of electrospun fibers , 1995 .
[32] Gustav Steinhoff,et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. , 2007, The Journal of thoracic and cardiovascular surgery.
[33] Z. Cui,et al. Collagen–chitosan polymer as a scaffold for the proliferation of human adipose tissue-derived stem cells , 2009, Journal of materials science. Materials in medicine.
[34] Jiyong Jin,et al. Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model , 2009, European journal of heart failure.
[35] Nikolay Bazhanov,et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.
[36] Yen Chang,et al. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. , 2008, Cardiovascular research.
[37] C. Ware,et al. The FASEB Journal • Research Communication , 2007 .
[38] Doris A Taylor,et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.
[39] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[40] C. Cannizzaro,et al. Practical aspects of cardiac tissue engineering with electrical stimulation. , 2007, Methods in molecular medicine.
[41] Joshua M Hare,et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[42] Sean P Sheehy,et al. Hierarchical architecture influences calcium dynamics in engineered cardiac muscle , 2011, Experimental biology and medicine.
[43] Milica Radisic,et al. Engineered cardiac tissues. , 2011, Current opinion in biotechnology.
[44] Cláudia Lobato da Silva,et al. Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia , 2009, Journal of cellular physiology.
[45] Li Qian,et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.
[46] Stefan Wagner,et al. Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.
[47] Fei Ye,et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.
[48] Fred H. Gage,et al. Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.
[49] N. Nishiyama,et al. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. , 2009, Biomaterials.
[50] Michelle Keramidas,et al. Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells. , 2009, Experimental cell research.
[51] P. Menasché. Skeletal myoblasts and cardiac repair. , 2008, Journal of molecular and cellular cardiology.
[52] D. Torella,et al. Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.
[53] Masayuki Yamato,et al. Cell sheet engineering for heart tissue repair. , 2008, Advanced drug delivery reviews.
[54] Alain Bel,et al. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. , 2011, Cardiovascular research.
[55] Yao‐Hua Song,et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. , 2007, European heart journal.
[56] S. Dymarkowski,et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.
[57] Milica Radisic,et al. Electrical stimulation systems for cardiac tissue engineering , 2009, Nature Protocols.
[58] O. Alfieri,et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.
[59] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[60] S. Wu,et al. In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice. , 2011, Life sciences.
[61] A. Ma,et al. The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. , 2011, Experimental cell research.
[62] Emmanuel Messas,et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study , 2005, The Lancet.
[63] K. Poh,et al. Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.
[64] Diego Gallo,et al. Bioreactors as engineering support to treat cardiac muscle and vascular disease. , 2013, Journal of healthcare engineering.
[65] Robert Lanza,et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.
[66] George Q. Daley,et al. Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.
[67] T. Lüscher,et al. Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Prehypertension: Relation to Endothelial Dysfunction , 2010, Hypertension.
[68] Tetsuo Sasano,et al. Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy , 2009, Circulation.
[69] Martin Fussenegger,et al. Microscale tissue engineering using gravity-enforced cell assembly. , 2004, Trends in biotechnology.
[70] V. Jeevanantham,et al. Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis , 2012, Circulation.
[71] Roberto Bolli,et al. Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology , 2006, Circulation.
[72] Shulamit Levenberg,et al. Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells , 2007, Circulation research.
[73] S. Perez,et al. Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.
[74] Gordana Vunjak-Novakovic,et al. Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in Situ , 2009, Cell transplantation.
[75] Wolfram-Hubertus Zimmermann,et al. Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle , 2006, Circulation.
[76] F. Mouquet,et al. CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation , 2005, Circulation research.
[77] P. Menasché. Cardiac cell therapy: lessons from clinical trials. , 2011, Journal of molecular and cellular cardiology.
[78] Benedikt Weber,et al. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. , 2013, Biomaterials.
[79] Thomas Eschenhagen,et al. Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[80] Rona Shofti,et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.
[81] Doris A Taylor,et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. , 2012, JAMA.
[82] É. Mousseaux,et al. Skeletal Myoblast Transplantation in Ischemic Heart Failure: Long-Term Follow-Up of the First Phase I Cohort of Patients , 2006, Circulation.
[83] Lila R Collins,et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.
[84] J. Krieger,et al. Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold , 2009, PloS one.
[85] Dejian Lai,et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.
[86] A. Bissery,et al. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. , 2005, European heart journal.
[87] Steven P Jones,et al. Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes: Insights Into the Development of Cell-Based Pacemakers , 2005, Circulation.
[88] Hyun-Jae Kang,et al. Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[89] Takashi Daimon,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.
[90] I. Komuro,et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo , 2007, The Journal of cell biology.
[91] L. Griffith,et al. Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.
[92] Takashi Aoi,et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.
[93] S. Ogawa,et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.
[94] T. Asahara,et al. CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.
[95] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[96] E. Taraldsrud,et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[97] H. Alkadhi,et al. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. , 2013, Biomaterials.
[98] Randall J Lee,et al. Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.
[99] Martin Fussenegger,et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. , 2006, Tissue engineering.
[100] Fen Chen,et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. , 2006, Tissue engineering.
[101] H. Alkadhi,et al. Intramyocardial Transplantation and Tracking of Human Mesenchymal Stem Cells in a Novel Intra-Uterine Pre-Immune Fetal Sheep Myocardial Infarction Model: A Proof of Concept Study , 2013, PloS one.
[102] K. Woodhouse,et al. Seeding bioreactor-produced embryonic stem cell-derived cardiomyocytes on different porous, degradable, polyurethane scaffolds reveals the effect of scaffold architecture on cell morphology. , 2008, Tissue engineering. Part A.
[103] G. Condorelli,et al. Vascular endothelial growth factors in cardiovascular medicine , 2008, Journal of cardiovascular medicine.
[104] S. Gronthos,et al. Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair , 2008, Stem cells.
[105] M. Govoni,et al. Mechanostimulation Protocols for Cardiac Tissue Engineering , 2013, BioMed research international.
[106] Gordana Vunjak-Novakovic,et al. Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering , 2010, Biotechnology progress.
[107] Michael V Sefton,et al. A modular approach to cardiac tissue engineering. , 2010, Tissue engineering. Part A.
[108] R. Stewart,et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.
[109] Theo Kofidis,et al. Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.
[110] Xian‐Zheng Zhang,et al. Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. , 2009, Acta biomaterialia.
[111] R. Levine,et al. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. , 2006, Journal of the American College of Cardiology.
[112] M. Khorasani,et al. Fabrication of microporous polyurethane by spray phase inversion method as small diameter vascular grafts material. , 2006, Journal of biomedical materials research. Part A.
[113] G. Vunjak‐Novakovic,et al. Channelled scaffolds for engineering myocardium with mechanical stimulation , 2012, Journal of tissue engineering and regenerative medicine.
[114] Megan L. McCain,et al. A tissue-engineered jellyfish with biomimetic propulsion , 2012, Nature Biotechnology.
[115] I. Weissman,et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.
[116] R J Cohen,et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. , 1999, American journal of physiology. Heart and circulatory physiology.
[117] J. Roncalli,et al. Mesenchymal Stem Cells Promote Matrix Metalloproteinase Secretion by Cardiac Fibroblasts and Reduce Cardiac Ventricular Fibrosis After Myocardial Infarction , 2009, Stem cells.
[118] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[119] R. Lederman,et al. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. , 2008, European heart journal.
[120] Richard T. Lee,et al. Stem-cell therapy for cardiac disease , 2008, Nature.
[121] R K Birla,et al. Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. , 2007, Tissue engineering.
[122] Marcus F Stoddard,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.
[123] P. Anversa,et al. Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.
[124] S. Yamanaka,et al. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors , 2007, Cell proliferation.
[125] P. Galie,et al. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[126] Lars S. Maier,et al. Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells , 2008, Circulation.
[127] P. Doevendans,et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. , 2008, Stem cell research.
[128] Artur Lichtenberg,et al. A multifunctional bioreactor for three-dimensional cell (co)-culture. , 2005, Biomaterials.
[129] Gordana Vunjak-Novakovic,et al. Bioengineering heart muscle: a paradigm for regenerative medicine. , 2011, Annual review of biomedical engineering.
[130] J. Hubbell,et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. , 2011, Biomaterials.
[131] Christian Krettek,et al. Influence of perfusion and compression on the proliferation and differentiation of bone mesenchymal stromal cells seeded on polyurethane scaffolds. , 2012, Biomaterials.
[132] Thomas Eschenhagen,et al. Engineering Myocardial Tissue , 2005, Circulation research.
[133] B. Torok-Storb,et al. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. , 2002, Blood.
[134] J. Feijen,et al. A facile method to fabricate poly(L-lactide) nano-fibrous morphologies by phase inversion. , 2010, Acta biomaterialia.
[135] Karl-Ludwig Laugwitz,et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2005, Nature.
[136] Smadar Cohen,et al. Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat , 2008, Circulation.
[137] Jianwen Luo,et al. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue , 2012, Journal of tissue engineering and regenerative medicine.
[138] Yen Chang,et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. , 2008, Cardiovascular research.
[139] Tal Dvir,et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome , 2009, Proceedings of the National Academy of Sciences.
[140] B. Strauer,et al. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.
[141] M. Zviman,et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. , 2009, European heart journal.
[142] Robert E. Nordon,et al. Design of bioreactors for mesenchymal stem cell tissue engineering , 2008 .
[143] Alain Carpentier,et al. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. , 2008, The Annals of thoracic surgery.
[144] P. E. McHugh,et al. Bioreactors for Cardiovascular Cell and Tissue Growth: A Review , 2003, Annals of Biomedical Engineering.
[145] Smadar Cohen,et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. , 2009, Journal of the American College of Cardiology.
[146] Bernke J Papenburg,et al. One-step fabrication of porous micropatterned scaffolds to control cell behavior. , 2007, Biomaterials.
[147] W. Zimmermann,et al. Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.
[148] F J Schoen,et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. , 1999, Biotechnology and bioengineering.
[149] R Langer,et al. Biomimetic approach to cardiac tissue engineering , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.
[150] Hidezo Mori,et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.
[151] K. Rufibach,et al. Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction: Effects on Global Left Ventricular Function , 2013, Circulation.
[152] F. Yuan,et al. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. , 2011, Journal of pharmaceutical sciences.
[153] T. Okano,et al. Tissue Cardiomyoplasty Using Bioengineered Contractile Cardiomyocyte Sheets to Repair Damaged Myocardium: Their Integration with Recipient Myocardium , 2005, Transplantation.
[154] Bernke J Papenburg,et al. Development and analysis of multi-layer scaffolds for tissue engineering. , 2009, Biomaterials.
[155] J. Vacanti,et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. , 2000, Tissue engineering.
[156] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[157] D. Kraitchman,et al. Serial Noninvasive In Vivo Positron Emission Tomographic Tracking of Percutaneously Intramyocardially Injected Autologous Porcine Mesenchymal Stem Cells Modified for Transgene Reporter Gene Expression , 2008, Circulation. Cardiovascular imaging.
[158] S R Gonda,et al. Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. , 1999, Tissue engineering.
[159] D. Francis,et al. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. , 2013, International journal of cardiology.
[160] B. Seifert,et al. Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. , 2013, European heart journal.
[161] T. Okano,et al. Composite Cell Sheets: A Further Step Toward Safe and Effective Myocardial Regeneration by Cardiac Progenitors Derived From Embryonic Stem Cells , 2010, Circulation.
[162] Hong Liu,et al. A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling , 2007, Stem cells.
[163] Shunichi Homma,et al. Composite scaffold provides a cell delivery platform for cardiovascular repair , 2011, Proceedings of the National Academy of Sciences.
[164] N. Bursac,et al. Cardiomyocyte Cultures With Controlled Macroscopic Anisotropy: A Model for Functional Electrophysiological Studies of Cardiac Muscle , 2002, Circulation research.
[165] P. Doevendans,et al. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. , 2011, Cardiovascular research.
[166] T. Lüscher,et al. "Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease. , 2012, Current vascular pharmacology.
[167] Milica Radisic,et al. Challenges in cardiac tissue engineering. , 2010, Tissue engineering. Part B, Reviews.
[168] C. Bearzi,et al. Human cardiac stem cells , 2005, Proceedings of the National Academy of Sciences.
[169] T. Couffinhal,et al. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. , 2004, The Annals of thoracic surgery.
[170] M. Kotaki,et al. A review on polymer nanofibers by electrospinning and their applications in nanocomposites , 2003 .
[171] J. Lima,et al. CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging. , 2011, JACC. Cardiovascular imaging.
[172] Richard A. Lasher,et al. The mechanically enhanced phase separation of sprayed polyurethane scaffolds and their effect on the alignment of fibroblasts. , 2010, Biomaterials.
[173] D. Wendt,et al. The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.
[174] A. Terzic,et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.
[175] Peter A. Altman,et al. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy: Functional Recovery and Reverse Remodeling , 2011, Circulation research.
[176] Martin Fussenegger,et al. Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units. , 2006, Tissue engineering.
[177] Gordana Vunjak-Novakovic,et al. Scaffold stiffness affects the contractile function of three‐dimensional engineered cardiac constructs , 2010, Biotechnology progress.
[178] William Wijns,et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. , 2013, Journal of the American College of Cardiology.
[179] R. Hitchcock,et al. Engineered channels enhance cellular density in perfused scaffolds. , 2011, Acta biomaterialia.
[180] T. Asahara,et al. Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.
[181] K. Healy,et al. Biomimetic matrices for myocardial stabilization and stem cell transplantation. , 2010, Journal of biomedical materials research. Part A.
[182] Milica Radisic,et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[183] E. Olson. A decade of discoveries in cardiac biology , 2004, Nature Medicine.
[184] I. Sekiya,et al. Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality , 2002, Stem cells.
[185] W. Zimmermann,et al. Cardiac Tissue Engineering: Implications for Pediatric Heart Surgery , 2009, Pediatric Cardiology.
[186] Stefan Wagner,et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. , 2013, European heart journal.
[187] Milica Radisic,et al. Influence of substrate stiffness on the phenotype of heart cells , 2010, Biotechnology and bioengineering.
[188] Yong-Fu Xiao,et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. , 2002, Journal of applied physiology.
[189] C. Murry,et al. Cell therapy enhances function of remote non-infarcted myocardium. , 2009, Journal of molecular and cellular cardiology.
[190] E. Andreu,et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.
[191] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[192] C A van Blitterswijk,et al. 3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties. , 2006, Biomaterials.
[193] M. Al-mallah,et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. , 2007, Archives of internal medicine.
[194] Gordana Vunjak-Novakovic,et al. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. , 2003, Tissue engineering.
[195] M. Tendera,et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem , 2009, European heart journal.
[196] Andrew D McCulloch,et al. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. , 2008, Biophysical journal.
[197] A. Hagège,et al. Transplantation of Autologous Fresh Bone Marrow Into Infarcted Myocardium: A Word of Caution , 2003, Circulation.
[198] Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. , 2011, Tissue engineering. Part A.
[199] Darrell H. Reneker,et al. Electrospinning jets and polymer nanofibers , 2008 .
[200] Milica Radisic,et al. Optical mapping of impulse propagation in engineered cardiac tissue. , 2009, Tissue engineering. Part A.
[201] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[202] Martin Fussenegger,et al. VEGF profiling and angiogenesis in human microtissues. , 2005, Journal of biotechnology.
[203] Joshua M Hare,et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[204] K. Książek. A comprehensive review on mesenchymal stem cell growth and senescence. , 2009, Rejuvenation research.
[205] P. Genever,et al. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. , 2010, Tissue engineering. Part C, Methods.
[206] A. Reinisch,et al. Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression , 2012, Circulation.
[207] Dinender K. Singla,et al. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. , 2011, Molecular pharmaceutics.
[208] Li Deng,et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. , 2009, Biomaterials.
[209] Scott J Hollister,et al. Scaffold engineering: a bridge to where? , 2009, Biofabrication.
[210] J. Cooper-White,et al. Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. , 2007, Biomaterials.
[211] Randall J Lee,et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.
[212] Milica Radisic,et al. Materials science and tissue engineering: repairing the heart. , 2013, Mayo Clinic proceedings.
[213] Lior Gepstein,et al. Controlling the Cellular Organization of Tissue‐Engineered Cardiac Constructs , 2004, Annals of the New York Academy of Sciences.
[214] D. Mastroeni,et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. , 2010, Cardiovascular research.
[215] A. Glass,et al. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. , 2011, The Journal of thoracic and cardiovascular surgery.